Last update 08 Mar 2025
Kineta, Inc. (Washington)

Kineta, Inc. (Washington)

Public Company | Subsidiary Company|
2008|
Washington, United States
|
10-50
| NASDAQ: KA|
www.kinetabio.com

Overview

Tags

Neoplasms
Hemic and Lymphatic Diseases
Other Diseases
Antibody
Monoclonal antibody
Biological products

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases3
Neoplasms3
Infectious Diseases2
Nervous System Diseases1
Immune System Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Monoclonal antibody2
Biological products1
Small molecule drug1
Antibody1
Top 5 TargetCount
VISTA(V-domain Ig suppressor of T-cell activation)2
nAChRs(Nicotinic receptors)1
CD27(CD27 antigen)1
Envelope (E) protein1

Related

5
Drugs associated with Kineta, Inc. (Washington)
KVA-12.1
Target
VISTA
Mechanism
VISTA inhibitors
Active Org.
Kineta, Inc. [+1]
Originator Org.
Kineta, Inc.
Active Indication
Advanced Malignant Solid Neoplasm [+16]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
LHF-535
Target
Envelope (E) protein
Mechanism
Envelope (E) protein inhibitors
Active Org.
National Institutes of HealthNational Institutes of Health [+3]
Originator Org.
Kineta SA
Active Indication
Lassa Fever
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
KCP-506
Target
nAChRs
Mechanism
Nicotinic receptors antagonists
Active Org.
Kineta, Inc. (Washington)Kineta, Inc. (Washington) [+1]
Originator Org.
Kineta, Inc.
Active Indication
Neuralgia
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Kineta, Inc. (Washington)
NL-OMON36904
/ CompletedNot Applicable
A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE ESCALATION STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF A SUBCUTANEOUS DOSE OF SHK-186 IN HEALTHY SUBJECTS - ShK-186 SAD study
100 Clinical Results associated with Kineta, Inc. (Washington)
Login to view more data
0 Patents (Medical) associated with Kineta, Inc. (Washington)
Login to view more data
100 Deals associated with Kineta, Inc. (Washington)
Login to view more data
100 Translational Medicine associated with Kineta, Inc. (Washington)
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Preclinical
Phase 1
3
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free